Biotech · Private company
Invitae Corporation
Track this companyFree. Adds Invitae Corporation to your Dealase workspace and tells you when its record changes.
Clinical trials51 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- Germline genetic testingPancreatic AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Invitae multi-cancer gene panelProstate CancerClinicalTrials.gov · fetched Nov 12, 2026
- Invitae's 84 gene multi-cancer panel.CancerClinicalTrials.gov · fetched Nov 12, 2026
- Personalized Cancer Monitoring (PCM)CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Universal Germline Testing in the CommunityUNKNOWN · started Jun 1, 2022ClinicalTrials.gov NCT05416710 · fetched Nov 12, 2026
- MRD Assay Evaluates Recurrence and Response Via a Tumor Informed AssessmentACTIVE_NOT_RECRUITING · started Nov 29, 2021ClinicalTrials.gov NCT05219734 · fetched Nov 12, 2026
- ARTEMIS: Study of Patients With Early Stage Pancreatic Cancer Who Have Undergone Genetic TestingTERMINATED · started Aug 23, 2021ClinicalTrials.gov NCT05380557 · fetched Nov 12, 2026
- PROCLAIM: Germline Genetic Testing for Prostate Cancer PatientsCOMPLETED · started Nov 1, 2019ClinicalTrials.gov NCT05447637 · fetched Nov 12, 2026
- A Web-based Observational Study of Patient-reported Outcomes in Adults With NarcolepsyCOMPLETED · started Jul 8, 2015ClinicalTrials.gov NCT02769780 · fetched Nov 12, 2026